|
||||||||||||||||||||||||||||||||||||||
|
RESULTS AND ACHIEVEMENTS |
||||||||||||||||||||||||||||||||||||||
The examinations have been conducted in the period of 6 to 12 months
|
 |
Application of nutraceuticals:
|
By the monitoring of tumor parameters in the group of patients on the chemo- or/and radioterapy, which had started to administer these nutraceuticals, in the extensive phases of oncologic therapy, there has been noticed tumor regression in the 24% of cases, which is concerned to be a synergic effect
|
|
||||||||||||||||||||||||||||||||||
|
Application of Gonebazol
|
Reduces the period of cell recovery on 20 days Radiation lesions are reduced in 70% of cases, without inflammations, necrosis and other side effects The radiation side effects are reduced in 75% of clinically monitored patients on the chemo- and radiotherapy |
|||||||||||||||||||||||||||||||||||||
|
Application of the complete bioprotocol
|
§The nutraceuticals of comparative therapy were applied in the group of patients who have completed specific oncologic treatment The quality of life was improved in 95% of cases
In this group of
examinees there has been established the anti-tumor effect in 10-30%
especially in the hematologic malignant diseases (lymphoma and leukemia)
and in the carcinoma of well-vascularized organs (primary tumors or
metastases on lungs
|
|||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
